SARS-CoV-2 Myocarditis Diagnostic Probability (Troponin + MRI + ECG)
Clinical findings
Enter the available findings to display the original heuristic point total.
Clinical context and limitations
Troponin indicates myocardial injury, not its cause. ECG abnormalities may support suspicion but are not specific. CMR using the revised 2018 Lake Louise Criteria can provide evidence of myocardial inflammation when a T2-based marker of edema and a T1-based marker of myocardial injury are present in an appropriate clinical setting.
Neither troponin elevation nor CMR alone proves that inflammation is caused by SARS-CoV-2. Consider the full clinical presentation and competing diagnoses, including acute coronary syndrome, MINOCA, pericarditis, stress cardiomyopathy, other infectious or immune-mediated myocarditis, and non-inflammatory myocardial injury.
How to interpret this tool
- The displayed points reproduce the supplied heuristic, not a validated clinical prediction rule.
- No patient-level probability, sensitivity, specificity, or treatment recommendation can be inferred from the total.
- A negative or indeterminate CMR does not independently exclude myocarditis; timing, protocol, image quality, and pre-test probability matter.
- Urgent clinical assessment is required for hemodynamic instability, significant ventricular arrhythmia, high-grade AV block, acute heart failure, or other signs of severe disease.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.